Fate Therapeutics(FATE) - 2025 Q2 - Quarterly Report

For the quarterly period ended June 30, 2025 OR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (IRS Employer Identification No.) 12278 Scripps Summit Drive, San Diego, CA 92131 (Address of principal executive offices) (Zip Code) (858) 875-1800 (Registrant's telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: ☐ TRANSITION REPORT ...